Altogether, these data suggest that loss of polycystin-mediated osmosensing disrupts the trafficking of AQP2 in patients with ADPKD, providing a potential explanation for their urine concentration deficiency. The gene discussed is AQP2; the disease is autosomal dominant polycystic kidney disease.